What is On Point?
On Point operates as a specialized youth development organization dedicated to mitigating high-risk behaviors among adolescents through structured mentorship and educational programming. By partnering with schools and community organizations, the firm provides a comprehensive framework that empowers teenagers to make informed, healthy life choices. With a reach extending across 40 states and four international territories, On Point has established itself as a pivotal player in the social impact sector.
The organization distinguishes itself through a dual-pronged operational model: direct service delivery to 15,000 local students annually and the dissemination of proprietary curriculum to external partners. This scalable approach to behavioral intervention has allowed On Point to maintain a significant footprint in the non-profit ecosystem, effectively bridging the gap between community-based support and institutional educational requirements.
How much funding has On Point raised?
On Point has raised a total of $314K across 2 funding rounds:
Debt
$150K
Debt
$164K
Debt (2020): $150K with participation from PPP
Debt (2021): $164K led by PPP
Key Investors in On Point
PPP
Public-Private Partnership
What's next for On Point?
With the recent influx of capital, On Point is positioned to accelerate its strategic expansion, focusing on the digitization of its training modules and the broadening of its international footprint. The organization is expected to prioritize the enhancement of its curriculum delivery systems, ensuring that its behavioral health programs remain relevant in an increasingly complex digital environment for youth.
Furthermore, the leadership team is likely to leverage this financial stability to deepen its partnerships with public and private school districts. By optimizing its operational infrastructure, On Point aims to increase the efficacy of its mentorship programs, thereby solidifying its market position as a leader in youth-focused social development and community health advocacy.